Well said. Considering historical overruns this is disturbing. Seems like there's a constant moving target. How about proving what you aim to do & deliver before moving the goalposts? The saying 'walk before you run' is prescient.
You'd think the share price would send a message to the Board. They need to hear that shareholders are unnerved. I'm emailing the Chairman of my concerns. Can I suggest others here do similarly?
- Forums
- ASX - By Stock
- KLL
- Ann: BSOPP Feasibility Study Complete - New 120ktpa Base Case
Ann: BSOPP Feasibility Study Complete - New 120ktpa Base Case, page-70
-
-
- There are more pages in this discussion • 279 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.28 |
Change
0.000(0.00%) |
Mkt cap ! $174.4K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KLL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online